Does Batten Grafting Improve Nasal Outcomes in Septoplasty and Turbinate Reduction?
Part of paid clinical trials in Poplar Bluff, Missouri.
- Sponsor
- Northwell Health
- Study ID
- NCT05287841
- Status
- Recruiting
Conditions
- Allergic Rhinitis
- Nasal Obstruction
- Nasal Polyps
- Nasal Valve Collapse
- Septal Defect
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Accepted
Interventions
- Batten batten graft — PROCEDUREThe batten grafts are autologous grafts from the patients' own tissue, produced from nasal septal quadrangular cartilage. This will be obtained during the septoplasty portion of the procedure. The batten graft will be used to stabilize the internal nasal valve and prevent nasal valve collapse on inspiration.
- Septoplasty — PROCEDUREA portion of the quadrangular cartilage of the nasal septum is removed. This will be performed as a standard septoplasty.
- Inferior Turbinate Reduction — PROCEDUREThe bilateral inferior turbinates will be surgically ablated.
Study Details
The objective of this study is to compare the effectiveness of batten grafts plus septoplasty and turbinate reduction (intervention arm) compared to septoplasty and turbinate reduction alone (control arm), both in terms of subjective and objective assessments.
Key Dates
- Start date
- Apr 30, 2021
- Status verified
- Sep 2024
- Primary completion
- Dec 31, 2024
- Completion
- Jun 15, 2025
Study Design
- Enrollment
- 96 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Batten graft, plus septoplasty and inferior turbinate reductionIn the intervention arm, a portion of the quadrangular cartilage of the nasal septum is also removed, but will be refashioned and re-implanted into the patient as an autologous batten graft. This will be performed together with standard septoplasty and turbinate reduction.
- Active Comparator: Septoplasty and inferior turbinate reduction aloneIn the control arm, a portion of the quadrangular cartilage of the nasal septum is removed. This will be performed as a standard septoplasty and turbinate reduction.
Primary Outcome Measure
Nasal Obstruction Symptom Evaluation (NOSE) score [ Time Frame: 12 months ]
Central Contacts
- Research Department718-226-6256
- David Hiltzik, MD212-434-4500
Locations (3)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Poplar Bluff Regional Medical Center | Poplar Bluff | Missouri | 63901 | Alexandros Georgolios, MD, FACS (PRINCIPAL_INVESTIGATOR) |
| Lenox Hill Hospital/Staten Island University Hospital | New York | New York | 10075 | David Hiltzik, MD (PRINCIPAL_INVESTIGATOR) Tristan Tham, MD (SUB_INVESTIGATOR) |
| Staten Island University Hospital | Staten Island | New York | 10305 | David Hiltzik, MD (PRINCIPAL_INVESTIGATOR) Tristan Tham (SUB_INVESTIGATOR) |
Find similar trials in Poplar Bluff, MO
Related Studies
- Nasal Obstruction With Oxymetazoline and CorticosteroidsPHASE2 · Recruiting · Washington University School of Medicine · St Louis, Missouri
- Antibiotic Prophylaxis in RhinoplastyPHASE3 · Enrolling By Invitation · Stanford University · Stanford, California
- Interleukin-4Ra Blockade by Dupilumab Decreases Staphylococcus Colonization and Increases Microbial Diversity in CRSwNPPHASE4 · Recruiting · University of Virginia · Charlottesville, Virginia
- Viral Mucosal ReprogrammingPHASE2 · Recruiting · The University of Texas Medical Branch, Galveston · Galveston, Texas